Marc D. Beer, Chief Executive Officer at Aegerion Pharmaceuticals, Inc. (AEGR), bought 10,065 shares at $11.91 ($120K) on 2011-08-09, disclosed to the SEC on 2011-08-10.
Scheduled purchase ($120k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.91 | 1,800 | $21K | 17.8% |
| 2 | $11.96 | 8,265 | $99K | 82.2% |
| Total | $11.95 avg | 10,065 | $120K | 100% |
| Filing → |
| BTMD | SELL | 2023-01-10 | $2.6M | — | Filing → |
| NERV | BUY | 2017-03-21 | $406K | — | Filing → |
| AEGR | BUY | 2014-07-31 | $337K | — | Filing → |